ANSS: Autonomic Monitoring in Neurocardiogenic Syncope

Sponsor
Children's Hospital Medical Center, Cincinnati (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05907018
Collaborator
(none)
40
1
30.7
1.3

Study Details

Study Description

Brief Summary

This is a prospective observational pilot study of suitability of autonomic monitoring via the VU-AMS device for prediction of neurocardiogenic syncope (NCS) in children referred to cardiopulmonary exercise testing (CPET) for a diagnosis of syncope. The study population is children referred for CPET to evaluate for neurocardiogenic syncope. The purpose is to describe autonomic function during rest and exercise and determine the positive predictive value of autonomic function measurements against the gold standard for diagnosis of neurocardiogenic syncope, the CPET. Children presenting for CPET with chest pain or who are status post orthotopic heart transplantation will serve as positive and negative controls respectively.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Comparing Phenotypic and Autonomic Physiologic Determinants of Neurocardiogenic Syncope
    Actual Study Start Date :
    May 12, 2023
    Anticipated Primary Completion Date :
    Jun 1, 2025
    Anticipated Study Completion Date :
    Dec 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Autonomic data respiratory sinus arrhythmia among patients with chest pain [Data collected throughout cardiopulmonary exercise testing. Up to 90 minutes.]

      Subjects will wear an ambulatory monitor during testing

    2. Autonomic data respiratory sinus arrhythmia among patients with syncope [Data collected throughout cardiopulmonary exercise testing. Up to 90 minutes.]

      Subjects will wear an ambulatory monitor during testing

    3. Autonomic data respiratory sinus arrhythmia among patients post heart transplant [Data collected throughout cardiopulmonary exercise testing. Up to 90 minutes.]

      Subjects will wear an ambulatory monitor during testing

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years to 24 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Parent/Legal guardian able to provide informed consent

    • Verbal participant assent

    • Undergoing clinically indicated CPET.

    • Diagnosis of either syncope, chest pain/dyspnea or status post OHT

    • Participant willing and able to participate in study procedures

    • Age 7-24 years

    Exclusion Criteria:
    • Participant unwilling or unable to participate

    • Contraindication to adhesive placement, eg, epidermolysis bullosa

    • Cancellation of the subject's planned CPET procedure.

    • Tracheostomy tube presence (this will prevent proper placement of impedance cardiogram lead)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cincinnati Children's Hospital Medical Center Cincinnati Ohio United States 45229

    Sponsors and Collaborators

    • Children's Hospital Medical Center, Cincinnati

    Investigators

    • Principal Investigator: Jamie Sinton, MD, Children's Hospital Medical Center, Cincinnati

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Children's Hospital Medical Center, Cincinnati
    ClinicalTrials.gov Identifier:
    NCT05907018
    Other Study ID Numbers:
    • 2022-0841
    First Posted:
    Jun 18, 2023
    Last Update Posted:
    Jun 18, 2023
    Last Verified:
    Jun 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 18, 2023